Sheng Zhao
Harbin, 150086, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Multiphase enhanced computed tomography features captured by delta radiomics reveal prognosis and tumor heterogeneity in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: October 23, 2025
A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study.
Journal: Journal of hepatocellular carcinoma
Published: March 02, 2025
Targeted Reprogramming of TREM2-Positive Macrophages and MRI-Guided Immune Monitoring in Colorectal Cancer Using CSF1R@Mn@MPDA-Antitrem2 Nanoplatform.
Journal: Advanced healthcare materials
Published: February 25, 2025
Author Correction: A radiomics nomogram based on MSCT and clinical factors can stratify fibrosis in inflammatory bowel disease.
Journal: Scientific reports
Published: March 14, 2024
Comparison of Tumor Non-specific and PD-L1 Specific Imaging by Near-Infrared Fluorescence/Cerenkov Luminescence Dual-Modality In-situ Imaging.
Journal: Molecular imaging
Published: January 30, 2024
The Effect of Histogram Analysis of DCE-MRI Parameters on Differentiating Renal Tumors.
Journal: Clinical laboratory
Published: November 10, 2023
A radiomics nomogram based on MSCT and clinical factors can stratify fibrosis in inflammatory bowel disease.
Journal: Scientific reports
Published: September 15, 2023
A Comprehensive Prediction Model Based on MRI Radiomics and Clinical Factors to Predict Tumor Response After Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Journal: Academic radiology
Published: February 19, 2023
Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Journal: Academic radiology
Published: November 11, 2022
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer.
Journal: EJNMMI research
Published: April 05, 2022
A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature.
Journal: Frontiers in oncology
Published: January 21, 2022
Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: December 01, 2021
Last Updated: 09/26/2026